 Julie O'Donnell |
KYNE, specialty healthcare communications firm, has become a lead investor in Medit, an artificial intelligence based medical education platform. Medit co-founder Julie O’Donnell will serve as KYNE’s global head of digital, leading digital strategy and oversee the firm’s digital resources.
Before starting up Medit, O’Donnell held executive positions at Danish pharmaceutical company Lundbeck and Publicis D Healthcare, engaging healthcare stakeholders across such therapeutic areas as psychiatry, neurology and diabetes.
KYNE’s investment is part of a move to beef up its digital services, analytics tools and media capabilities. Medit curates sources including medical journals, blogs, websites and podcasts, and then uses machine learning to create customized recommended content for medical professionals.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
